Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Bolt Biotherapeutics Inc stock (Bolt Biotherapeutics Inc)

Buy Bolt Biotherapeutics Inc stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Bolt Biotherapeutics, a San Francisco-based company that develops immuno-oncology therapeutics, completed an upsized $220 million IPO, selling 11.5 million shares $20 each.

The stock opened at $26.10 on Friday and jumped more than 25% shortly after it opened for trading.

Our top picks for where to buy Bolt Biotherapeutics stock

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, and options with as little as $1
  • After-hours trading available
  • Earn 4.5% interest on uninvested cash with Gold
  • 24/7 customer support

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Complimentary access to a financial planner

How to buy Bolt Biotherapeutics Inc stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BOLT. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Bolt Biotherapeutics Inc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
OPTO
Finder Score: 3.8 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Robinhood
Finder Score: 4.6 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
SoFi Invest®
Finder Score: 4.3 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
Uphold
Finder Score: 3.6 / 5: ★★★★★
Crypto alternative
Uphold
★★★★★
Cryptocurrency
N/A
$0
4.65%
Get $10
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Public.com
Finder Score: 4.4 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Bolt Biotherapeutics Inc stock price (NASDAQ: BOLT)

Use our graph to track the performance of BOLT stocks over time.

Bolt Biotherapeutics Inc shares at a glance

Information last updated 2024-11-28.
Latest market close$0.63
52-week range$0.54 - $1.56
50-day moving average $0.63
200-day moving average $0.85
Wall St. target price$1.75
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-1.71

Is it a good time to buy Bolt Biotherapeutics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bolt Biotherapeutics Inc price performance over time

Historical closes compared with the close of $0.6406 from 2024-11-29

1 week (2024-11-27) 2.33%
1 month (2024-11-04) -4.10%
3 months (2024-09-03) -5.77%
6 months (2024-06-04) -15.47%
1 year (2023-12-04) -29.88%
2 years (2022-12-02) -55.82%
3 years (2021-12-03) 10.5
5 years (2019-11-30) N/A

Bolt Biotherapeutics Inc financials

Revenue TTM $11.2 million
Gross profit TTM $1.6 million
Return on assets TTM -29.41%
Return on equity TTM -58.04%
Profit margin 0%
Book value $2.96
Market Capitalization $24 million

TTM: trailing 12 months

Bolt Biotherapeutics Inc share dividends

We're not expecting Bolt Biotherapeutics Inc to pay a dividend over the next 12 months.

You may also wish to consider:

Bolt Biotherapeutics Inc share price volatility

Over the last 12 months, Bolt Biotherapeutics Inc's shares have ranged in value from as little as $0.54 up to $1.56. A popular way to gauge a stock's volatility is its "beta".

BOLT.US volatility(beta: 0.92)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bolt Biotherapeutics Inc's is 0.916. This would suggest that Bolt Biotherapeutics Inc's shares are less volatile than average (for this exchange).

To put Bolt Biotherapeutics Inc's beta into context you can compare it against those of similar companies.

Bolt Biotherapeutics Inc overview

Bolt Biotherapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc. , Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University.

Frequently asked questions

null
What percentage of Bolt Biotherapeutics Inc is owned by insiders or institutions?
Currently 3.457% of Bolt Biotherapeutics Inc shares are held by insiders and 58.192% by institutions.
How many people work for Bolt Biotherapeutics Inc?
Latest data suggests 100 work at Bolt Biotherapeutics Inc.
When does the fiscal year end for Bolt Biotherapeutics Inc?
Bolt Biotherapeutics Inc's fiscal year ends in December.
Where is Bolt Biotherapeutics Inc based?
Bolt Biotherapeutics Inc's address is: 900 Chesapeake Drive, Redwood City, CA, United States, 94063
What is Bolt Biotherapeutics Inc's ISIN number?
Bolt Biotherapeutics Inc's international securities identification number is: US0977021049

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site